DM Neurology (Movement Disorders and Demyelinating Disease) — Thesis Title List
42 titles · instant objectives
-
001
Non-motor symptoms in Parkinson's disease and their impact on quality of life
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
002
Cognitive impairment in Parkinson's disease: prevalence, profile and correlation with disease severity
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
003
Clinical spectrum and etiology of dystonia in patients attending a movement disorder clinic
Movement Disorders
Prospective observational study
Descriptive Study
-
004
Clinical profile and outcome of Wilson's disease with neurological presentation
Movement Disorders
Prospective observational study
Descriptive Study
-
005
Transcranial sonography of the substantia nigra in Parkinson's disease versus atypical parkinsonism
Movement Disorders
Prospective diagnostic study
Diagnostic Accuracy Study
-
006
Clinical, radiological and outcome profile of multiple sclerosis and neuromyelitis optica spectrum disorder at a tertiary care centre
Demyelinating Disease
Prospective observational study
Descriptive Study
-
007
Optical coherence tomography of the retinal nerve fibre layer as a marker of axonal loss in multiple sclerosis
Demyelinating Disease
Case-control study
Case-Control Study
-
008
Clinical profile and outcome of acute disseminated encephalomyelitis in adults
Demyelinating Disease
Retrospective record-based study
Descriptive Study
-
009
Cognitive dysfunction in patients with multiple sclerosis and its correlation with MRI lesion load
Demyelinating Disease
Hospital-based cross-sectional study
Cross-sectional Study
-
010
Clinical spectrum and etiology of ataxia in adults attending a tertiary care neurology clinic
Movement Disorders
Prospective observational study
Descriptive Study
-
011
Cutaneous phosphorylated alpha-synuclein on skin biopsy in Parkinson's disease versus atypical parkinsonism
Movement Disorders
Prospective diagnostic study
Diagnostic Accuracy Study
-
012
Prevalence of REM sleep behaviour disorder in Parkinson's disease and its association with cognitive impairment
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
013
Prevalence and risk factors of levodopa-induced dyskinesia in Parkinson's disease
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
014
Clinical profile and non-motor features of essential tremor
Movement Disorders
Hospital-based cross-sectional study
Descriptive Study
-
015
Outcome of botulinum toxin therapy in cervical dystonia and hemifacial spasm
Movement Disorders
Prospective observational study
Prospective Study
-
016
Gait parameters and fall risk in Parkinson's disease using the Timed Up and Go test
Movement Disorders
Prospective observational study
Prospective Study
-
017
MR parkinsonism index in differentiating progressive supranuclear palsy from Parkinson's disease and multiple system atrophy
Movement Disorders
Prospective diagnostic study
Diagnostic Accuracy Study
-
018
Prevalence of orthostatic hypotension and cardiovascular autonomic dysfunction in Parkinson's disease
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
019
Etiological spectrum of chorea in adults at a tertiary care centre
Movement Disorders
Prospective observational study
Descriptive Study
-
020
Clinical and radiological profile and relapse rate of MOG antibody-associated disease in adults
Demyelinating Disease
Prospective observational study
Descriptive Study
-
021
Clinical and MRI features of MOG antibody-associated disease, AQP4-positive NMOSD and multiple sclerosis: a comparative study
Demyelinating Disease
Hospital-based cross-sectional study
Comparative Study
-
022
Relapse rate and CD19 monitoring in neuromyelitis optica spectrum disorder treated with rituximab
Demyelinating Disease
Prospective observational study
Prospective Study
-
023
Central vein sign on susceptibility-weighted MRI in differentiating multiple sclerosis from its mimics
Demyelinating Disease
Prospective diagnostic study
Diagnostic Accuracy Study
-
024
Antibody status and visual outcome of acute optic neuritis
Demyelinating Disease
Prospective observational study
Prospective Study
-
025
Fatigue and depression in multiple sclerosis and their impact on quality of life
Demyelinating Disease
Hospital-based cross-sectional study
Cross-sectional Study
-
026
Serum neurofilament light chain as a marker of disease activity in multiple sclerosis
Demyelinating Disease
Prospective observational study
Prospective Study
-
027
Serum vitamin D levels in demyelinating disorders and their association with relapses
Demyelinating Disease
Case-control study
Case-Control Study
-
028
Adherence to disease-modifying therapy and disability progression in relapsing multiple sclerosis
Demyelinating Disease
Prospective observational study
Prospective Study
-
029
Prodromal markers (hyposmia, constipation, autonomic dysfunction and mild motor signs) in patients with isolated REM sleep behaviour disorder
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
030
Plasma phosphorylated tau-217 in Parkinson disease with cognitive impairment and its correlation with cognitive test scores
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
031
Effect of a structured physiotherapy programme with external cueing on freezing of gait in Parkinson disease
Movement Disorders
Prospective comparative study
Comparative Study
-
032
Prevalence and clinical correlates of impulse control disorders in patients with Parkinson disease on dopamine agonists
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
033
Relapse risk during pregnancy and the postpartum period in AQP4-positive neuromyelitis optica spectrum disorder and MOG antibody-associated disease
Demyelinating Disease
Retrospective record-based study
Descriptive Study
-
034
Atypical presentations of neuromyelitis optica spectrum disorder including area postrema syndrome, brainstem and cerebral syndromes
Demyelinating Disease
Retrospective record-based study
Descriptive Study
-
035
Rituximab versus mycophenolate mofetil for relapse prevention in relapsing MOG antibody-associated disease
Demyelinating Disease
Prospective comparative study
Comparative Study
-
036
Prevalence and electrophysiological pattern of peripheral neuropathy in Parkinson disease on long-term levodopa and its association with vitamin B12 and homocysteine
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
037
Retinal nerve fibre layer thickness on optical coherence tomography and its correlation with motor severity and cognition in Parkinson disease
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
038
Surface electromyography tremor analysis for differentiating essential tremor, dystonic tremor and parkinsonian tremor in a movement disorder clinic
Movement Disorders
Hospital-based cross-sectional study
Diagnostic Accuracy Study
-
039
Posterior fossa CSF volume and neurovascular conflict on MRI in primary hemifacial spasm and their correlation with spasm severity
Movement Disorders
Hospital-based cross-sectional study
Cross-sectional Study
-
040
Clinical, imaging and cardiac profile of genetically confirmed Friedreich ataxia at a tertiary care centre
Movement Disorders
Prospective observational study
Descriptive Study
-
041
Relapse rate and disability progression with rituximab versus other off-label disease-modifying therapies in relapsing multiple sclerosis
Demyelinating Disease
Prospective observational study
Comparative Study
-
042
Incidence of serious infections and hypogammaglobulinaemia in patients with multiple sclerosis and NMOSD on long-term rituximab
Demyelinating Disease
Prospective observational study
Prospective Study